Pierre‐Emmanuel Bonté

692 total citations
11 papers, 163 citations indexed

About

Pierre‐Emmanuel Bonté is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Pierre‐Emmanuel Bonté has authored 11 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Pierre‐Emmanuel Bonté's work include Immunotherapy and Immune Responses (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Ferroptosis and cancer prognosis (2 papers). Pierre‐Emmanuel Bonté is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Ferroptosis and cancer prognosis (2 papers). Pierre‐Emmanuel Bonté collaborates with scholars based in France, United States and Argentina. Pierre‐Emmanuel Bonté's co-authors include Christel Goudot, Sebastián Amigorena, Antonela Merlotti, Elina Zueva, Montserrat Carrascal, Clémence Basse, Cécile Alanio, Nicolas Girard, Zev A. Binder and Colleen M. Lau and has published in prestigious journals such as Nature Immunology, Cell Reports and Cancer Discovery.

In The Last Decade

Pierre‐Emmanuel Bonté

10 papers receiving 162 citations

Peers

Countries citing papers authored by Pierre‐Emmanuel Bonté

Since Specialization

Citations

This map shows the geographic impact of Pierre‐Emmanuel Bonté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Emmanuel Bonté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Emmanuel Bonté more than expected).

Fields of papers citing papers by Pierre‐Emmanuel Bonté

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐Emmanuel Bonté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Emmanuel Bonté. The network helps show where Pierre‐Emmanuel Bonté may publish in the future.

Co-authorship network of co-authors of Pierre‐Emmanuel Bonté

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐Emmanuel Bonté. A scholar is included among the top collaborators of Pierre‐Emmanuel Bonté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐Emmanuel Bonté. Pierre‐Emmanuel Bonté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Evaluation of Proton Minibeam Radiotherapy on Antitumor Immune Responses in a Rat Model of Glioblastoma 2025 ·Cancer Immunology Research ·Lorea Iturri, Miriam Riquelme‐Perez, Pierre‐Emmanuel Bonté, (unknown), Christel Goudot, Marjorie Juchaux, (unknown), Cristèle Gilbert, (unknown), (unknown), Annalisa Patriarca, Ludovic De Marzi, Sebastián Amigorena, Yolanda Prezado	0
2	Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal 2024 ·Lung Cancer ·(unknown), Clémence Basse, Fanny Lebossé, Pierre‐Emmanuel Bonté, Nicolas Girard, M. Duruisseaux	4
3	SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors 2023 ·Cancer Discovery ·Sheila López‐Cobo, (unknown), Paul Gueguen, Pierre‐Emmanuel Bonté, Kyriaki Tsalkitzi, (unknown), Salomé Glauzy, Armelle Bohineust, (unknown), (unknown), Zélia Gouveia, Christel Goudot, Franck Perez, Michael Saitakis, Sebastián Amigorena	34
4	Single-cell RNA-seq analysis reveals dual sensing of HIV-1 in blood Axl+ dendritic cells 2023 ·iScience ·(unknown), Francesca Nadalin, Pierre‐Emmanuel Bonté, Ouardia Aït-Mohamed, Constance Delaugerre, Jean‐Daniel Lelièvre, Florent Ginhoux, Nicolas Ruffin, Philippe Benaroch	7
5	Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer 2023 ·Lung Cancer ·Clémence Basse, Julien Ancel, Marie-Ange Massiani, Pierre‐Emmanuel Bonté, (unknown), (unknown), Maud Milder, Kim Cao, Catherine Daniel, Pauline du Rusquec, Marie‐Paule Sablin, Youlia Kirova, Édouard Sage, Arnaud Beddok, Nicolas Girard	2
6	Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment 2023 ·Science Immunology ·Pierre‐Emmanuel Bonté, (unknown), Sandrine Heurtebise-Chrétien, (unknown), (unknown), (unknown), Leticia Laura Niborski, Elina Zueva, Eliane Piaggio, Agathe Seguin‐Givelet, Nicolas Girard, Cécile Alanio, Marianne Burbage, Christel Goudot, Sebastián Amigorena	12
7	Clusterin protects mature dendritic cells from reactive oxygen species mediated cell death 2023 ·OncoImmunology ·(unknown), Antonela Merlotti, Pierre‐Emmanuel Bonté, (unknown), (unknown), Christel Goudot, Fernando Erra Díaz, (unknown), Ana Ceballos, Sebastián Amigorena, Jorge Geffner, Juan Sabatté	4
8	ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment 2022 ·Nature Immunology ·Javiera Villar, Adeline Cros, Alba de Juan, (unknown), Pierre‐Emmanuel Bonté, Colleen M. Lau, Ioanna Tiniakou, Boris Reizis, Élodie Segura	31
9	Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach 2022 ·Lung Cancer ·Clémence Basse, (unknown), Pierre‐Emmanuel Bonté, Isabelle Fromantin, Nicolas Girard	14
10	Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides 2022 ·Cell Reports ·Pierre‐Emmanuel Bonté, (unknown), Antonela Merlotti, Montserrat Carrascal, (unknown), Elina Zueva, Zev A. Binder, Cécile Alanio, Christel Goudot, Sebastián Amigorena	35
11	Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN) 2019 ·OncoImmunology ·Antonela Merlotti, (unknown), Paula Michea, Pierre‐Emmanuel Bonté, Christel Goudot, (unknown), Nicolás Gonzalo Núñez, Christine Sedlik, Ana Ceballos, Vassili Soumelis, Sebastián Amigorena, Jorge Geffner, Eliane Piaggio, Juan Sabatté	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact